Key Insights

Highlights

Success Rate

96% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

1.6%

1 terminated out of 62 trials

Success Rate

96.2%

+9.6% vs benchmark

Late-Stage Pipeline

5%

3 trials in Phase 3/4

Results Transparency

24%

6 of 25 completed with results

Key Signals

6 with results96% success

Data Visualizations

Phase Distribution

46Total
Not Applicable (28)
P 1 (4)
P 2 (11)
P 3 (2)
P 4 (1)

Trial Status

Completed25
Recruiting15
Unknown10
Active Not Recruiting5
Not Yet Recruiting3
Withdrawn2

Trial Success Rate

96.2%

Benchmark: 86.5%

Based on 25 completed trials

Clinical Trials (62)

Showing 20 of 20 trials
NCT04963283Phase 2Active Not Recruiting

Study of Cabozantinib and Nivolumab in Refractory Metastatic Microsatellite Stable (MSS) Colorectal Cancer

NCT02738359Completed

Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening

NCT04907643Not ApplicableRecruiting

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT04916990Not ApplicableRecruiting

Improving Care for Rural Patients With Solid Tumors

NCT05652361Not ApplicableRecruitingPrimary

Machine Learning-based Surgical Guidance System for Robot-assisted Rectal Surgery

NCT06715839Not ApplicableRecruiting

Target-specific immunoPET Imaging of Digestive System Carcinoma

NCT05400122Phase 1Suspended

Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer

NCT07137000Not ApplicableActive Not Recruiting

The Effect of Art Therapy in Patients Undergoing Colorectal Cancer

NCT05715255Not ApplicableRecruiting

Adaptive Symptom Self-Management Immunotherapy Study

NCT06950996Completed

A Clinical Evaluation of AI Solutions Developed in the CHAIMELEON Project for Cancer: Prostate, Lung, Breast, Colon and Rectum

NCT03573791Recruiting

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT06812728Phase 2RecruitingPrimary

Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients

NCT04015804Not ApplicableCompletedPrimary

Robotic Low Rectum Anterior Resection

NCT06805045Not ApplicableRecruitingPrimary

Image-Guided Surgery In The Treatment Of Rectal Cancer (AR_CRC)

NCT03345563Not ApplicableCompleted

Project HERO: Health Empowerment & Recovery Outcomes

NCT06530303Phase 1Recruiting

Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer

NCT06601985Active Not RecruitingPrimary

Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer.

NCT06567756Not ApplicableNot Yet RecruitingPrimary

Conformal Sphincter-Preservation Operation Versus InterSphincteric Resection on Anal Function in Low Rectal Cancer

NCT06458725Not ApplicableNot Yet RecruitingPrimary

Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers

NCT04755920Phase 2Recruiting

SGM-101 in Colorectal Brain Metastases.

Scroll to load more

Research Network

Activity Timeline